Correlation Between AstraZeneca PLC and Bayer AG

Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Bayer AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Bayer AG into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AstraZeneca PLC and Bayer AG NA, you can compare the effects of market volatilities on AstraZeneca PLC and Bayer AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Bayer AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Bayer AG.

Diversification Opportunities for AstraZeneca PLC and Bayer AG

0.79

Correlation Coefficient

AstraZeneca PLC  Bayer AG

Poor diversification

The 3 months correlation between AstraZeneca and Bayer is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC and Bayer AG NA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bayer AG NA and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC are associated (or correlated) with Bayer AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bayer AG NA has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Bayer AG go up and down completely randomly.

Pair Corralation between AstraZeneca PLC and Bayer AG

Assuming the 90 days trading horizon AstraZeneca PLC is expected to generate 0.63 times more return on investment than Bayer AG. However, AstraZeneca PLC is 1.58 times less risky than Bayer AG. It trades about -0.1 of its potential returns per unit of risk. Bayer AG NA is currently generating about -0.19 per unit of risk. If you would invest  14,195  in AstraZeneca PLC on September 17, 2024 and sell it today you would lose (1,550) from holding AstraZeneca PLC or give up 10.92% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

AstraZeneca PLC  vs.  Bayer AG NA

AstraZeneca PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AstraZeneca PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Bayer AG NA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bayer AG NA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with AstraZeneca PLC and Bayer AG

The main advantage of trading using opposite AstraZeneca PLC and Bayer AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Bayer AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bayer AG will offset losses from the drop in Bayer AG's long position.

The idea behind AstraZeneca PLC and Bayer AG NA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..